GlassScriptPhysician profile
Matthew L Welsh
NPI 1528471422
$4,750.57
in general payments reported to CMS, 2019-2025
21 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,521 · 2021: $1,520 · 2022: $94.84 · 2023: $174 · 2024: $27.01 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reel Surgical, INC. | $3,330.36 | 2020-2021 | |
| Stryker Corporation | $547.97 | 2020-2023 | T2, Gamma |
| Depuy Synthes Sales INC. | $161.59 | 2020-2025 | Na |
| Smith+Nephew, INC. | $96.90 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System |
| Bioventus LLC | $88.58 | 2022-2025 | Durolane |
| Anika Therapeutics, INC. | $72.99 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $71.93 | 2024-2025 | |
| Skeletal Dynamics INC | $52.34 | 2020 | |
| Acumed LLC | $48.11 | 2025 | Acumed, Innate Implant |
| Endo USA, INC. | $43.16 | 2025 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $39.22 | 2021-2025 | Exparel |
| Merck Sharp & Dohme LLC | $37.25 | 2025 | |
| Pacira Therapeutics, INC. | $33.56 | 2021 | |
| Innovation Technologies INC | $24.66 | 2022 | |
| Davol INC. | $23.80 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $19.97 | 2025 | Restrata Wound Matrix |
| Guard Medical INC. | $16.90 | 2025 | Npseal |
| Ethicon US, LLC | $14.78 | 2020 | |
| Heraeus Medical, LLC. | $12.74 | 2025 | |
| Ibsa Pharma INC. | $11.08 | 2021 | |
| Embody, INC. | $2.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Welsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.